{"DataElement":{"publicId":"3776036","version":"1","preferredName":"Charlson Comorbidity Index Chart Review Version Has Metastatic Solid Tumor Type","preferredDefinition":"Text term that decribes the kind of metastatic solid tumor(s) an individual has or had, determined by reviewing information from the medical record.","longName":"CCI_ METASTASES_TP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3775844","version":"1","preferredName":"Charlson Comorbidity Index Chart Review Version Has Metastatic Solid Tumor","preferredDefinition":"A method of predicting mortality by weighting comorbid conditions calculated by reviewing an individual's chart.__A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site._A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","longName":"3775629v1.0:3775842v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3775629","version":"1","preferredName":"Charlson Comorbidity Index Chart Review Version","preferredDefinition":"A method of predicting mortality by weighting comorbid conditions calculated by reviewing an individual's chart.","longName":"C106374","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Charlson Comorbidity Index Derived from Chart Review","conceptCode":"C106374","definition":"A method of predicting mortality by weighting comorbid conditions calculated by reviewing an individual's chart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE7DE01D-2532-E657-E040-BB89AD4356E9","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3775842","version":"1","preferredName":"Metastatic Solid Neoplasm","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.:Cancer of body tissues other than blood, bone marrow, or the lymphatic system.","longName":"C14174:C9292","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE81E3E8-A1F0-2ADC-E040-BB89AD4329FE","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCI:Charlson Comorbidity Index, Charlson, ME, 1987","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE81E3E8-A201-2ADC-E040-BB89AD4329FE","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for RTOG per request by V.Patel. mc 6/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3775981","version":"1","preferredName":"Metastatic Solid Neoplasm Type","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site._Cancer of body tissues other than blood, bone marrow, or the lymphatic system._Something distinguishable as an identifiable class based on common qualities.","longName":"3775981v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Specify Other Metastatic Malignant Neoplasm","ValueMeaning":{"publicId":"3775982","version":"1","preferredName":"Specify Other Metastatic Malignant Neoplasm","longName":"3775982","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.: A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.--2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Metastatic Malignant Neoplasm","conceptCode":"C36263","definition":"A malignant tumor that has spread from its original (primary) site of growth to another site close to or distant from the primary site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE8224EE-CCB4-B892-E040-BB89AD4353A2","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE8224EE-CCCD-B892-E040-BB89AD4353A2","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","deletedIndicator":"No"},{"value":"Melanoma","valueDescription":"Metastatic Melanoma","ValueMeaning":{"publicId":"3775984","version":"1","preferredName":"Metastatic Melanoma","longName":"3775984","preferredDefinition":"A melanoma that has spread from its primary site to another anatomic site.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Melanoma","conceptCode":"C8925","definition":"A melanoma that has spread from its primary site to another anatomic site.  Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE8224EE-CCDA-B892-E040-BB89AD4353A2","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE8224EE-CCF3-B892-E040-BB89AD4353A2","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","deletedIndicator":"No"},{"value":"Lung","valueDescription":"Metastatic Lung Carcinoma","ValueMeaning":{"publicId":"3775985","version":"1","preferredName":"Metastatic Lung Carcinoma","longName":"3775985","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.: A carcinoma originating in the lung.  Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas.  Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas.  Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lung Carcinoma","conceptCode":"C4878","definition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE8224EE-CD00-B892-E040-BB89AD4353A2","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE8224EE-CD19-B892-E040-BB89AD4353A2","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","deletedIndicator":"No"},{"value":"Prostate","valueDescription":"Metastatic Prostate Carcinoma","ValueMeaning":{"publicId":"3775987","version":"1","preferredName":"Metastatic Prostate Carcinoma","longName":"3775987","preferredDefinition":"A carcinoma that arises from the prostate gland and has spread to other anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Prostate Carcinoma","conceptCode":"C8946","definition":"A carcinoma that arises from the prostate gland and has spread to other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE8224EE-CD26-B892-E040-BB89AD4353A2","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE8224EE-CD3F-B892-E040-BB89AD4353A2","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","deletedIndicator":"No"},{"value":"Colon","valueDescription":"Metastatic Colon Carcinoma","ValueMeaning":{"publicId":"3775988","version":"1","preferredName":"Metastatic Colon Carcinoma","longName":"3775988","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.: A malignant tumor usually arising from the epithelium lining the large intestinal mucosa.  Colon carcinoma is one of the most common malignancies in both males and females, and is especially common in North America and Europe.  Grossly, most colon carcinomas are polypoid or ulcerating lesions. Microscopically, adenocarcinoma is the most frequently seen morphologic subtype.  Prognosis depends on the stage of the disease (depth of invasion, metastasis to regional/distal lymph nodes or other anatomic sites). -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Colon Carcinoma","conceptCode":"C4910","definition":"A malignant epithelial neoplasm that arises from the colon and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE8224EE-CD4C-B892-E040-BB89AD4353A2","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE8224EE-CD65-B892-E040-BB89AD4353A2","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","deletedIndicator":"No"},{"value":"Breast","valueDescription":"Metastatic Breast Carcinoid Tumor","ValueMeaning":{"publicId":"3775990","version":"1","preferredName":"Metastatic Breast Carcinoid Tumor","longName":"3775990","preferredDefinition":"A carcinoid tumor that arises from the breast and has metastasized to other anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Breast Neuroendocrine Tumor G1","conceptCode":"C5171","definition":"A well differentiated neuroendocrine tumor that arises from the breast and has metastasized to other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE8224EE-CD72-B892-E040-BB89AD4353A2","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DE8224EE-CD8B-B892-E040-BB89AD4353A2","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3775980","version":"1","preferredName":"Metastatic Solid Neoplasm Type","preferredDefinition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.:Cancer of body tissues other than blood, bone marrow, or the lymphatic system.:Something distinguishable as an identifiable class based on common qualities.","longName":"C14174:C9292:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE8224EE-CC88-B892-E040-BB89AD4353A2","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"ONEDATA","dateModified":"2013-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCI:Charlson Comorbidity Index, Charlson, ME, 1987","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE8224EE-CC99-B892-E040-BB89AD4353A2","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"COOPERM","dateModified":"2013-06-07","changeDescription":"Created for RTOG per request by V.Patel. mc 6/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3775608","version":"1","longName":"CCI (Charlson Comorbidity Index)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3775609","version":"1","longName":"CCI","context":"NCIP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104935","version":"1","longName":"RTOG-1221","context":"NRG"}]}],"AlternateNames":[{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"CCI_ METASTASES_TP","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Has the patient had a metasta","type":"Preferred Question Text","description":"Has the patient had a metastatic solid tumor? (METASTASES)","url":null,"context":"NCIP"}],"origin":"CCI:Charlson Comorbidity Index, Charlson, ME, 1987","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DE833B93-BA69-4010-E040-BB89AD437C42","latestVersionIndicator":"Yes","beginDate":"2013-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-06-06","modifiedBy":"FORMBUILDER","dateModified":"2014-07-25","changeDescription":"Created for RTOG per request by V.Patel. mc 6/6/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}